Topical anesthetics are also often used for preparation prior to minimally invasive procedures such as (among others):
The proprietary formulation of NeuroMed7® includes both skin conditioners and other ingredients added to improve absorption and efficacy. NeuroMed7® will typically not cause a profound reddening effect of the skin when applied as directed.
NeuroMed7®, FA and LA can be dispensed directly to consumers at high retail margins. NeuroMed7®, LA and FA are compliant OTC topical anesthetic healthcare products that do not require prescription for retail dispensing purposes. Compare cost per gram to leading brands such as EMLA, LMX and Dr. Numb!
Features and Benefits
NeuroMed branded topical anesthetics can be applied to intact skin to reduce pain locally. When properly applied, topical anesthetics are both safe and effective for use prior to minimally invasive dermal instrumentation procedures and to temporarily mitigate the pain, burn and itch sensations caused by irritating conditions of the skin.
The active ingredient in NeuroMed7® is lidocaine HCl 4%. The formulation also includes, ethoxydiglycol, MSM and propylene glycol, which are all commonly used to enhance absorption of therapeutics.
The active ingredient in NeuroMed FA is benzocaine 20%. The formulation also includes, ethoxydiglycol, MSM and propylene glycol, which are all commonly used to enhance absorption of therapeutics.
The active ingredient in NeuroMed LA is tetracaine 2%. The formulation also includes, ethoxydiglycol, MSM and propylene glycol, which are all commonly used to enhance absorption of therapeutics.
OTC TOPICAL – FDA MONOGRAPH COMPLIANT 21 CFR – 348 Topical Analgesics and Anesthetics
FDA NDC# REGISTERED 54723-175-22
Indication: NeuroMed7® (lidocaine HCl 4%) Cream is indicated for use on intact skin in adults and children 2 years and older to provide topical local analgesia for superficial dermatological procedures. Contraindications: NeuroMed7® Cream is contraindicated in patients with a known history of sensitivity to lidocaine, or local anesthetics of the amide or ester type and is also contraindicated in patients with sensitivity to any component of the product. Warnings/Precautions: Methemoglobinemia has been associated with use of local anesthetics such as lidocaine. NeuroMed7® Cream should be used with caution in patients with severe hepatic disease. When using NeuroMed7® Cream in conjunction with other local anesthetic agents, the total dose of anesthetic should be considered due to the potential for additive systemic toxic effects. Contact with the eyes should be avoided.
This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your local licensed doctor about medical concerns.